GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Certara Inc (HAM:700) » Definitions » Total Receivables

Certara (HAM:700) Total Receivables : €95.8 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Certara Total Receivables?

Certara's Total Receivables for the quarter that ended in Sep. 2024 was €95.8 Mil.


Certara Total Receivables Historical Data

The historical data trend for Certara's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Certara Total Receivables Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
Get a 7-Day Free Trial 47.12 53.27 69.30 83.83 85.52

Certara Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.96 85.52 82.02 91.09 95.78

Certara Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Certara Total Receivables Related Terms

Thank you for viewing the detailed overview of Certara's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Certara Business Description

Traded in Other Exchanges
Address
100 Overlook Center, Suite 101, Princeton, NJ, USA, 08540
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Certara Headlines

No Headlines